Amplitude Vascular Systems

Earlier this week, a few of our team members including Dr. Robert Chisena and Sean Gilligan sat down for a roundtable + walk & talk with Matthew Boyd, CCO of Boyd Biomedical, and Brian Johnson, President of MassMEDIC, to shoot a new episode for their video series, Boyd Biomedical Design Stories. In this edition, Robert and Sean discuss AVS’ approach to intravascular lithotripsy and our PULSE IVL technology.   We’re thrilled to have been selected for the video series. Stay tuned for the full episode!   #medtech #medicaldevices

On this symbolic day, may we celebrate our freedom, salute those who made this possible and keep it safe, and stand in unity as a nation. Wishing everyone a safe and Happy Independence Day!

We are glad to share another great addition to our team: Justin Lovelace, Principal Regulatory Specialist. Justin has over 15 years of experience in the medical device industry. Justin will be responsible for the development and execution of regulatory strategies in line with our company vision. Welcome to the team, Justin!    #medicaldevices #medtech

We’re happy to share that we’ve welcomed another exemplary member to the AVS team, Head of Supply Chain and Procurement, Marek Barwinski! Marek comes to us with 12 years of global manufacturing experience spanning the fields of electronics, fluid technologies, medical devices, and orthopedics. We’re thrilled to have you on our team, Marek!    #medicaldevices #medtech 

Welcome to the AVS team Jonathan!

Mark Toland, our Chairman of the Board, was recently interviewed by Jim Hammerand at Medical Design & Outsourcing to discuss our investigational device exemption (IDE) approval from the FDA. To learn more about our technology, its differentiators, and our future plans, check out the article here: https://bit.ly/3VuCNHZ. #medicaldevices #medtech

#ICYMI: We received an investigational device exemption (IDE) from the FDA to begin our pivotal trial for PIVL therapy! We’re proud to be one of the first companies to conduct a peripheral intravascular lithotripsy IDE trial in the United States. Learn more: https://lnkd.in/e77Az8Yi   #medicaldevices #medtech 

We’re thrilled to welcome Jonathan Mulligan to the AVS team as our Senior Clinical Research Associate! Jonathan has over ten years of experience in clinical research. His experiences includes clinical studies of microfixation devices for cardiac procedures, total knee and total hip arthroplasty systems, and microfixation devices for maxillofacial surgery procedures, to name a few. We’re so glad to have you on our team, Jonathan!    #medicaldevices #medtech

We’re excited to announce that we have received investigational device exemption (IDE) from the FDA to begin our pivotal trial for pulsatile intravascular lithotripsy (PIVL) therapy. The POWER-PAD-II clinical study will evaluate the safety and efficacy of our Pulse IVL™ System for the treatment of patients with severely calcified peripheral arterial disease in the United States.     “We are proud to be one of the first companies to conduct a peripheral intravascular lithotripsy pivotal IDE trial in the US. The IDE approval marks our most significant clinical milestone to date as we approach FDA clearance and market availability for the Pulse IVL™ System, which is designed to easily deliver therapy across complex calcified lesions and reduce overall procedural costs.”  -Mark Toland, Chairman of the Board of AVS     Learn more about our intravascular lithotripsy study: https://lnkd.in/eEBCN8dG #medicaldevices #medtech  

Today, we honor and remember those who paid the ultimate sacrifice in service to our country and to their families: We are forever in your debt. We thank you and we proudly remember you. May the spirit of Memorial Day remind us of the price of freedom and inspire us to live with gratitude and compassion. #memorialday